Detalhe da pesquisa
1.
Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation.
Blood Adv
; 8(1): 194-206, 2024 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38052042
2.
Correctly structured problem lists lead to better and faster clinical decision-making in electronic health records compared to non-curated problem lists: A single-blinded crossover randomized controlled trial.
Int J Med Inform
; 180: 105264, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37890203
3.
Ixazomib, daratumumab and low-dose dexamethasone in intermediate-fit patients with newly diagnosed multiple myeloma: an open-label phase 2 trial.
EClinicalMedicine
; 63: 102167, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37680948
4.
Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19.
JAMA Oncol
; 8(10): 1477-1483, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35951338
5.
Trauma and psychotic symptoms: data from a pediatric mental health inpatient unit.
J Trauma Stress
; 24(4): 491-4, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21818783
6.
A Systematic Review of Cost-Effectiveness Analyses of Novel Agents in the Treatment of Multiple Myeloma.
Cancers (Basel)
; 13(22)2021 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34830761
7.
Decrease in early mortality for newly diagnosed multiple myeloma patients in the Netherlands: a population-based study.
Blood Cancer J
; 11(11): 178, 2021 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34764237
8.
Improving the identification of frail elderly newly diagnosed multiple myeloma patients.
Leukemia
; 35(9): 2715-2719, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33589752